Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
How does keytruda's price compare to competitors?Is there scientific research indicating a potential impact of cosentyx on women's reproductive abilities?Ibrutinib patent expiry canada?Belantamab list price?Veozah generic available?
See the DrugPatentWatch profile for Edarbyclor
Edarbyclor (azilsartan medoxomil + chlorthalidone) is indicated for the treatment of essential (primary) hypertension in adults when blood pressure is not adequately controlled with azilsartan medoxomil or chlorthalidone alone [1].
The combination is used when monotherapy with either azilsartan medoxomil or chlorthalidone does not bring blood pressure under adequate control [1].
No—its listed indication is for essential hypertension in adults, as a combination therapy for inadequate response to the individual components [1].
Other Questions About Edarbyclor :